Global Tumor Ablation Market 2015-2019 - Growing Focus on R&D

Jan 12, 2016, 05:10 ET from Research and Markets

DUBLIN, January 12, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/w38xqw/global_tumor) has announced the addition of the "Global Tumor Ablation Market 2015-2019" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.

Growing focus on R&D, increasing healthcare facilities in emerging countries, and rise in accessibility of advanced laser treatments may reduce the high cost of tumor ablation treatments and drugs used in chemotherapy.

According to the report, the minimally invasive surgeries or procedures are less painful and can be performed as outpatient procedure, unlike traditional surgeries. These surgeries are emerging as potential replacements for conventional therapeutic cancer surgeries. These surgeries are used for the treatment of various tumors of the prostate gland, lungs, and the liver. Further, robotic navigation technologies that perform ablation procedures more accurately are being incorporated to increase the popularity of these surgeries.

Further, the report states that the cost of tumor ablation treatment is directly proportional to the size of the tumor and the number of probes required for the surgery.

Key questions answered in the report include: 

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global tumor ablation market?
  • What are the Key market trends impacting the growth of the global tumor ablation market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global tumor ablation market?
  • What are the market opportunities and threats faced by the vendors in the global tumor ablation market?
  • Trending factors influencing the market shares of the EMEA, Americas, and APAC?
  • What are the key outcomes of the five forces analysis of the global tumor ablation market?

Companies Mentioned: 

  • AngioDynamics
  • Boston Scientific
  • Ethicon
  • Medtronic
  • Alpinion Medical System
  • BSD Medical
  • Conmed
  • C2 Therapeutics
  • CSA Medical
  • C.R. Bard
  • Chongqing Haifu Medical Technology
  • Esaote
  • EDAP TMS
  • Galil Medical
  • InSightec
  • Misonix
  • Mermaid Medical
  • Monteris

Key Topics Covered: 

PART 01: Executive summary

PART 02: Scope of the report 

PART 03: Market research methodology

PART 04: Introduction 

PART 05: Cancer statistics 

PART 06: Pipeline analysis 

PART 07: Market landscape 

PART 08: Market segmentation by ablation technology

PART 09: Market segmentation by cancer types

PART 10: Geographical segmentation 

PART 11: Market drivers 

PART 12: Impact of drivers 

PART 13: Market challenges 

PART 14: Impact of drivers and challenges 

PART 15: Market trends 

PART 16: Vendor landscape 

PART 17: Key vendor analysis 

For more information visit http://www.researchandmarkets.com/research/w38xqw/global_tumor


About Research and Markets 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


SOURCE Research and Markets